Biotech companies by one-year price change
How far the share price has moved over the last 52 weeks.
Moderna leads the 24 biotech companies ranked by one-year price change, at +755%, ahead of Kodiak Sciences (+396%) and Twist Bioscience (+340%). Figures as of 18 Nov 2026, 18:41 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- Moderna+755%
- Median
- +40.0%
- Combined market value
- AED 3.09T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ModernaMRNA · Health Care | +755% | AED 296.8B | AED 733.59 | 3.42% down | 755% up | ||
| 2 | Kodiak SciencesKOD · Health Care | +396% | AED 23.2B | AED 355.23 | 0.08% down | 396% up | ||
| 3 | Twist BioscienceTWST · Health Care | +340% | AED 29.7B | AED 434.90 | 5.72% up | 340% up | ||
| 4 | ImmunityBioIBRX · Health Care | +193% | AED 26.2B | AED 24.66 | 7.27% up | 193% up | ||
| 5 | Revolution MedicinesRVMD · Health Care | +131% | AED 127.6B | AED 589.74 | 1.30% down | 131% up | ||
| 6 | Adaptive BiotechnologiesADPT · Health Care | +88.1% | AED 17.1B | AED 105.76 | 1.07% up | 88% up | ||
| 7 | Kymera TherapeuticsKYMR · Health Care | +87.5% | AED 38.3B | AED 448.45 | 0.48% up | 87% up | ||
| 8 | CG OncologyCGON · Health Care | +85.3% | AED 26.3B | AED 294.67 | 1.63% up | 85% up | ||
| 9 | ExelixisEXEL · Health Care | +62.6% | AED 61.9B | AED 253.49 | 0.76% up | 63% up | ||
| 10 | BiogenBIIB · Health Care | +49.3% | AED 136.9B | AED 925.95 | 0.53% up | 49% up | ||
| 11 | Krystal BiotechKRYS · Health Care | +46.3% | AED 34.3B | AED 1,158.11 | 5.62% up | 46% up | ||
| 12 | ImmunovantIMVT · Health Care | +43.4% | AED 25.4B | AED 122.93 | 0.78% up | 43% up | ||
| 13 | Halozyme TherapeuticsHALO · Health Care | +36.6% | AED 40.3B | AED 353.87 | 0.40% up | 37% up | ||
| 14 | AmgenAMGN · Health Care | +33.7% | AED 886.8B | AED 1,639.50 | 2.52% down | 34% up | ||
| 15 | Gilead SciencesGILD · Health Care | +32.9% | AED 769.9B | AED 620.74 | 0.73% down | 33% up | ||
| 16 | Bio-TechneTECH · Health Care | +25.6% | AED 42B | AED 267.38 | 0.23% up | 26% up | ||
| 17 | VaxcytePCVX · Health Care | +22.2% | AED 34.1B | AED 215.65 | 1.15% down | 22% up | ||
| 18 | Neurocrine BiosciencesNBIX · Health Care | +20.2% | AED 61B | AED 602.23 | 1.18% down | 20% up | ||
| 19 | Scholar Rock HoldingSRRK · Health Care | +13.6% | AED 21.3B | AED 174.72 | 5.52% up | 14% up | ||
| 20 | QiagenQGEN · Health Care | +12.0% | AED 37.7B | AED 182.54 | 0.10% down | 12% up | ||
| 21 | RepligenRGEN · Health Care | +4.58% | AED 40.7B | AED 636.86 | 6.92% up | 5% up | ||
| 22 | argenxARGX · Health Care | +3.60% | AED 218.7B | AED 3,477.90 | 0.06% down | 4% up | ||
| 23 | BioNTechBNTX · Health Care | -16.3% | AED 76.4B | AED 308.11 | 1.14% down | 16% down | ||
| 24 | CRISPR TherapeuticsCRSP · Health Care | -20.9% | AED 14.8B | AED 152.26 | 3.25% up | 21% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6728 AED).
Questions and answers
Which biotech companies rank first by one-year price change?
Moderna (+755%), Kodiak Sciences (+396%) and Twist Bioscience (+340%) are the top three of the 24 biotech companies ranked by one-year price change as of 18 Nov 2026, 18:41 UTC.
How many biotech companies are in this ranking?
24 are ranked by one-year price change.
What are these biotech companies worth together?
The 24 biotech companies ranked by one-year price change have a combined market value of AED 3.09T as of 18 Nov 2026, 18:41 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Biotech companies by one-year price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.